658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-exi...
658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundAutoimmunity is associated with increased risk of malignancy. However, patients with pre-existing autoimmune diseases (AIDs) were excluded from immune checkpoint inhibitor (ICI) trials as these agents can cause immune-related adverse events (irAEs). Data are limited on the safety and efficacy of combination immunotherapy in this at-risk p...
Alternative Titles
Full title
658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4c4ed81616f04f1080b8fe2b0ecd46db
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4c4ed81616f04f1080b8fe2b0ecd46db
Other Identifiers
E-ISSN
2051-1426
DOI
10.1136/jitc-2020-SITC2020.0658
